- Home
- AADI vs TNYA Comparison
AADI vs TNYA Comparison
Compare AADI & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- TNYA
- Stock Information
- Founded
- AADI 2011
- TNYA 2016
- Country
- AADI United States
- TNYA United States
- Employees
- AADI N/A
- TNYA N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- AADI Health Care
- TNYA Health Care
- Exchange
- AADI Nasdaq
- TNYA Nasdaq
- Market Cap
- AADI 77.5M
- TNYA 74.7M
- IPO Year
- AADI N/A
- TNYA 2021
- Fundamental
- Price
- AADI $2.79
- TNYA $1.11
- Analyst Decision
- AADI Hold
- TNYA Strong Buy
- Analyst Count
- AADI 3
- TNYA 5
- Target Price
- AADI $1.75
- TNYA $17.50
- AVG Volume (30 Days)
- AADI 114.1K
- TNYA 1.9M
- Earning Date
- AADI 03-12-2025
- TNYA 03-17-2025
- Dividend Yield
- AADI N/A
- TNYA N/A
- EPS Growth
- AADI N/A
- TNYA N/A
- EPS
- AADI N/A
- TNYA N/A
- Revenue
- AADI $25,070,000.00
- TNYA N/A
- Revenue This Year
- AADI $8.43
- TNYA N/A
- Revenue Next Year
- AADI $5.41
- TNYA N/A
- P/E Ratio
- AADI N/A
- TNYA N/A
- Revenue Growth
- AADI 7.80
- TNYA N/A
- 52 Week Low
- AADI $1.21
- TNYA $0.86
- 52 Week High
- AADI $3.81
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- AADI 48.57
- TNYA 44.41
- Support Level
- AADI $2.56
- TNYA $1.43
- Resistance Level
- AADI $2.94
- TNYA $1.12
- Average True Range (ATR)
- AADI 0.13
- TNYA 0.10
- MACD
- AADI 0.01
- TNYA 0.05
- Stochastic Oscillator
- AADI 57.50
- TNYA 65.70
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.